Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
Clinical trial NCT07263438 · RECRUITING
Trial details
- NCT number
- NCT07263438
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-03
- Primary completion
- 2028-03-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.